Search - tctmd.com

Displaying 461 - 473 of 473

Sort: Relevancy | Date

News Industry News

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

July 18, 2011

News Industry News

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

July 11, 2011

News Industry News

Advanced Cardiac Therapeutics Announces CE Mark Clearance For Innovative Catheter System for the Treatment of Atrial Arrhythmias

June 10, 2011

News Industry News

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

May 18, 2011

News Industry News

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

May 12, 2011

News Conference News

Endothelial Shear Stress Works as a PREDICTION Tool

April 05, 2011

News Daily News

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Caitlin E. Cox

March 25, 2011

News Daily News

‘Mother-Child’ Technique Improves Success for PCI in Challenging Lesions

Caitlin E. Cox

March 03, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Caitlin E. Cox

January 25, 2011

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

News Daily News

PROSPECT Published: Combined IVUS Identifies Risky Nonculprit ACS Lesions

Caitlin E. Cox

January 18, 2011

News Daily News

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

Caitlin E. Cox

January 06, 2011

News Industry News

OrbusNeich Granted Expanded U.S. Patent of GenousTM Endothelial Progenitor Cell Capture Technology

January 03, 2011

Advertisement

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

Advanced Cardiac Therapeutics Announces CE Mark Clearance For Innovative Catheter System for the Treatment of Atrial Arrhythmias

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

Endothelial Shear Stress Works as a PREDICTION Tool

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

‘Mother-Child’ Technique Improves Success for PCI in Challenging Lesions

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

PROSPECT Published: Combined IVUS Identifies Risky Nonculprit ACS Lesions

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

OrbusNeich Granted Expanded U.S. Patent of GenousTM Endothelial Progenitor Cell Capture Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content